Kitchener Henry C, Trimble Edward L
UK National Cancer Research Institute and University of Manchester, Manchester, United Kingdom.
Int J Gynecol Cancer. 2009 Jan;19(1):134-40. doi: 10.1111/IGC.0b013e3181995f90.
There is a pressing need to improve our understanding of endometrial cancer (EC) and uterine carcinosarcoma and to develop new treatment strategies to improve outcomes. In recognition of this, a State of the Science meeting on EC was held last November 28 and 29, 2006, in Manchester, United Kingdom. The meeting was cosponsored by the National Cancer Research Institute (UK), the National Cancer Institute (US), and the Gynecological Cancer Intergroup. The objectives of the meeting were as follows: 1. To review current knowledge and understanding of EC and its treatments. 2. To identify key issues for translational research and clinical trials. 3. To identify the most important trials for women with endometrial carcinoma and uterine carcinosarcoma, both those already underway or to be done, for which the Gynecological Cancer Intergroup might facilitate international cooperation.
迫切需要增进我们对子宫内膜癌（EC）和子宫癌肉瘤的了解，并制定新的治疗策略以改善治疗效果。认识到这一点，2006年11月28日和29日在英国曼彻斯特举行了一次关于子宫内膜癌的科学现状会议。该会议由英国国家癌症研究所、美国国家癌症研究所和妇科癌症研究组共同主办。会议的目标如下：1. 回顾目前对子宫内膜癌及其治疗的认识和理解。2. 确定转化研究和临床试验的关键问题。3. 确定对于子宫内膜癌和子宫癌肉瘤患者最重要的试验，包括那些已经在进行或即将进行的试验，妇科癌症研究组可能会促进这些试验的国际合作。
